Skip to main
DLB
DLB logo

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories Inc. is experiencing continued growth in the adoption of its Atmos and Vision technologies across various devices, leading to an optimistic forecast regarding its engagement with original equipment manufacturers (OEMs). The company anticipates that profit growth will surpass revenue growth, attributing this expectation to operational leverage derived from its high gross margins. Additionally, increased stability in foundational revenue trends is expected to enhance the positive impact of the rising adoption of Dolby's technologies on overall revenue growth.

Bears say

Dolby Laboratories Inc is facing persistent pressure on its foundational revenue trends, attributed to tariff uncertainties that have resulted in softer performance than anticipated for fiscal 2025. The company has experienced ongoing challenges since the pandemic, particularly following an initial surge in device purchases, which has negatively impacted sustained revenue growth. Overall, these factors contribute to a negative outlook for the stock, as fundamental revenue trends continue to be adversely affected.

Dolby Laboratories (DLB) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 4 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $95.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $95.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.